Limited efficacy of a therapeutic anti-CD40 monoclonal antibody to inhibit activated CD4 T cell autoimmunity in vitro

• Chelsea Gootjes,

  Roles Conceptualization, Investigation, Methodology, Visualization, Writing – original draft

  Affiliation Department of Internal Medicine, Section Immunomodulation and Regenerative Cell Therapy, Leiden University Medical Center, Leiden, The Netherlands

  https://orcid.org/0000-0002-6811-2290

  ⨯
• Jaap Jan Zwaginga,

  Roles Writing – review & editing

  Affiliation Department of Internal Medicine, Section Immunomodulation and Regenerative Cell Therapy, Leiden University Medical Center, Leiden, The Netherlands

  ⨯
• Tatjana Nikolic,

  Roles Methodology, Supervision, Writing – review & editing

  Affiliation Department of Internal Medicine, Section Immunomodulation and Regenerative Cell Therapy, Leiden University Medical Center, Leiden, The Netherlands

  ⨯
• Bart O. Roep

  Roles Conceptualization, Supervision, Visualization, Writing – review & editing

  * E-mail: boroep@lumc.nl

  Affiliation Department of Internal Medicine, Section Immunomodulation and Regenerative Cell Therapy, Leiden University Medical Center, Leiden, The Netherlands

  https://orcid.org/0000-0002-3110-7391

  ⨯